Anaplastic thyroid carcinoma on 68 Ga-PSMA PET/CT: opening new frontiers
- 2 January 2018
- journal article
- editorial
- Published by Springer Nature in European Journal of Nuclear Medicine and Molecular Imaging
- Vol. 45 (4) , 667-668
Abstract
No abstract availableThis publication has 10 references indexed in Scilit:
- PSMA expression by microvasculature of thyroid tumors – Potential implications for PSMA theranosticsScientific Reports, 2017
- PSMA Expression in Tumor Neovasculature Endothelial Cells of Follicular Thyroid Adenoma as Identified by Molecular Imaging Using 68Ga-PSMA Ligand PET/CTClinical Nuclear Medicine, 2017
- Imaging of Prostate-Specific Membrane Antigen Expression in Metastatic Differentiated Thyroid Cancer Using 68Ga-HBED-CC-PSMA PET/CTClinical Nuclear Medicine, 2017
- Aspecific Uptake of 68GA-PSMA in Paget Disease of the BoneClinical Nuclear Medicine, 2016
- PSMA Expression in Papillary Thyroid CarcinomaClinical Nuclear Medicine, 2016
- Unusual Uptake of Prostate Specific Tracer 68Ga-PSMA–HBED-CC in a Benign Thyroid NoduleNuclear Medicine and Molecular Imaging, 2016
- First evidence of PSMA expression in differentiated thyroid cancer using [68Ga]PSMA-HBED-CC PET/CTEuropean Journal of Nuclear Medicine and Molecular Imaging, 2015
- Expression of Prostate‐Specific Membrane Antigen in Normal and Malignant Human TissuesWorld Journal of Surgery, 2006
- Upregulation of prostate specific membrane antigen/folate hydrolase transcription by an enhancerGene, 2002
- Five different anti-prostate-specific membrane antigen (PSMA) antibodies confirm PSMA expression in tumor-associated neovasculature.1999